WHO has urged people at risk to keep up with their vaccinations with boosters. IMAGE: A healthcare worker administers a dose of iNCOVACC, an intranasal vaccine as a booster dose for a senior......
Homegrown vaccine maker Bharat Biotech will launch its intranasal COVID-19 vaccine iNCOVACC, the first of its kind in India, on January 26, the company's chairman and managing director Krishna Ella......
Bharat Biotech International Ltd (BBIL) on Monday said it has completed the phase-III and booster dose trials for its intranasal Covid-19 vaccine BBV154, and it has proven to be safe. Photograph:......
Founders of indigenous COVID-19 vaccine developer Bharat Biotech -- Krishna Ella and Suchitra Ella, along with Cyrus Poonawalla, the chairman and MD of another vaccine manufacturer Serum Institute......
Bharat Biotech on Wednesday said a study has demonstrated that a booster dose of Covaxin has a neutralising effect on the Omicron and Delta variants of COVID-19. Image used for representational......
The government is considering setting up air freight stations to enable direct movement of vaccines from pharmaceutical factories to the aircraft. From reducing dwell time at airports to faster......
The first vaccine candidate will be an intra-muscular one, followed by intra-dermal and nasal ones, depending on test results, reports Sohini Das. Photograph: Kind courtesy Bharat Biotech ......
Adjuvants may be added to a vaccine to produce more antibodies and longer lasting immunity thus minimising the dose of antigen needed. Hyderabad based Bharat Biotech, whose Covid-19 vaccine......
The Indian vaccine industry largely feels there are two ways in which vaccine innovation can be spurred - one, get a high price for the product and two, have the government buy a few hundred......
The procurement and distribution will be centralised though the government is yet to take a call on the initial number of doses that will be procured. India plans to create a digital......